United States

Steve Kemler

Director, Life Sciences Senior Analyst

Areas of focus: Life Sciences

ABOUT STEVE

In May 2020, Steve was selected as a senior analyst in RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions influencing middle market leaders. Steve’s focus is on the life sciences industry. 

Summary of experience

Steve manages the Philadelphia market NetSuite team and provides NetSuite consulting services to a variety of clients in industries including life sciences, technology and wholesale distribution. Steve leads projects that require complex integrations, customizations and complex finance requirements.

As a member of RSM’s life sciences team, Steve consistently supports clients in the industry across the country. He also participates in the PACT MedTech series and is involved in multiple regional and national life sciences initiatives.

Steve has deep technical expertise and has a keen ability to work with people at all levels of a company. As ERP implementations involve staff with various backgrounds and expertise, Steve ensures that strategic insights from all levels are considered.

Prior to joining RSM, Steve spent three years managing the implementation of NetSuite for a rapidly growing multinational CRO and providing software and services for collecting patient reported outcomes in clinical trials. This implementation required skills related to finance (multiple currency, multiple subsidiary), logistics (managing hundreds of thousands of serialized devices distributed to over 100 countries), project accounting and project management, and CRM.  Prior to this, Steve worked in a variety of technical and finance roles at a medical technology company.

Education

  • Master of Business Administration, University of Colorado - Boulder
  • Bachelor of Science in Engineering, computer engineering, Case Western Reserve University

RECENT PERSPECTIVES

Living and adapting with COVID-19

THE REAL ECONOMY

Living and adapting with COVID-19

Governments and businesses—including the middle market firms that constitute the real economy—will face new challenges.

Conditions ripe for strategic investment among life sciences companies

INSIGHT ARTICLE

Conditions ripe for strategic investment among life sciences companies

Here are some areas in which CMOs, CROs and life sciences companies with established product pipelines might consider investing right now.

Policy snapshot: Life sciences

INSIGHT ARTICLE

Policy snapshot: Life sciences

Biden plans to expand Medicare, a move that the Congressional Budget Office estimates would cut drug spending by $450 billion over 10 years.

2020 Election preview: Life sciences

INSIGHT ARTICLE

2020 Election preview: Life sciences

With the election approaching, RSM is looking at the economic stakes and the key issues for the life sciences industry.

INSIGHT ARTICLE

Amid pressure to reshore life science supply chains, challenges abound

We suggest stress-testing your supply chain to determine what the actual or opportunity costs of disruption might be.

ARTICLE

4 Critical Challenges that Life Sciences Firms Solve with Technology

Whether developing drug therapies, designing medical devices, or more, life sciences companies have complex technology needs.

INSIGHT ARTICLE

From preclinical to commercial: Refining the life sciences back office

Life sciences companies are inherently fast-paced and back-office investments must evolve to match the changing needs of the organization.

Cyberattacks threaten companies researching COVID-19 vaccine

INSIGHT ARTICLE

Cyberattacks threaten companies researching COVID-19 vaccine

More promise, more problems: Cyberattacks threaten life sciences companies researching COVID-19 vaccine.

INSIGHT ARTICLE

Four reasons life sciences companies should consider a Cloud ERP

A Software-as-a-Service platform delivers benefits of the cloud to life sciences companies, especially those with outsourced operations.

INSIGHT ARTICLE

Benefits of Using NetSuite’s Cloud ERP In The Life Sciences Industry

Having an ERP system like NetSuite in place can help life sciences companies adapt to the changes with agility and efficiency.

HOW CAN WE HELP YOU?

To discuss how our team can help your business, contact us by phone 800-274-3978.


CONTACT STEVE

+1 720 839 2413
steve.kemler@rsmus.com
Connect on Linkedin